Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Phoenix Group lifts financial guidance after strong 2024

(Sharecast News) - Phoenix Group impressed shareholders on Monday by reporting strong strategic and financial progress for 2024, helping the savings and retirement business to lift its cash generation and earnings targets for the next two years. Operating cash generation (OCG) totalled £1.40bn in 2024, up 22% year-on-year, helped by the strong delivery of recurring management actions, which are expected to produce around £300m in excess cash per annum, the company said.

With the £1.4bn OCG target being achieved two years early, Phoenix has now lifted its three-year OCG target from £4.4bn to £5.1bn over 2024 to 2026, and expects to grow OCG by a further mid-single digital percentage per annum going forward.

"We therefore expect to generate excess cash of £1.1bn across 2024-26 and this will be allocated in accordance with our capital allocation framework, with a clear focus on deleveraging," the company said.

Adjusted operating profits were up 31% at £825m in 2024, helped by profitable growth in both Pensions and Savings, and Retirement Solutions. The adjusted operating profit guidance for 2026 has been raised to £1.1bn from £900m previously.

The board recommended a 2.6% increase in the final dividend to 27.35p per share, taking the total payout for the year to 54p, up from 52.65p in 2023.

"We are ahead of plan from both a strategic and financial perspective, delivering Operating Cash Generation of £1.4bn two years ahead of our 2026 target," said chief executive Andy Briggs. "We continue to operate in the top half of our Shareholder Capital Coverage Ratio range and our strong cash generation has enabled us to repay debt whilst also investing in our business."

Phoenix repaid £250m of debt during the period, keeping its SII leverage ratio flat at 36%, with a further $250m repaid in February. The company is targeting a SII leverage ratio of around 30% by the end of 2026.

Shares were up 6.3% at 557p by 0908 GMT.

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.